Furthermore, the study also found that in human breast tumours, CARM1 expression is positively correlated with ERα levels in ER‐positive tumours but negatively correlated with tumour grade, indicating that CARM1 is an important epigenetic target in ER‐positive breast cancer [81]. The gene discussed is CARM1; the disease is neoplasm.